Forget extinction: U.S. company plans to bring back wooly mammoths

Wooly mammoths might be making a comeback thanks to Colossal Biosciences of the great state of Texas.

The Dallas-based company says it plans to take on the environmental issues that led to critical endangerment and perform the once seemingly impossible task of reviving long-extinct species.

Colossal announced it will pioneer the use of CRISPR technology along with other genome engineering technologies toward a practical working model of de-extinction initially focused on its long-term goals of successful restoration and rewilding of functional woolly mammoths, large proboscideans from the Ice Age, to the tundra, according to a press release.

It said genetic engineering applications expand beyond animals and have the potential to advance human health, enhance food production, reduce environmental impact, and optimize animal health and welfare.

Keep reading

Mosquitoes With Synthetic DNA Scheduled For California Release

In the mosquito breeding rooms of British biotech company Oxitec, scientists line up fresh eggs, each the size of a grain of salt. Using microscopic needles, the white-coated researchers inject each egg with a dab of a proprietary synthetic DNA.

For four days, Oxitec technicians care for the eggs, watching for those that hatch into wriggling brown larvae. Those “injection survivors,” as the company calls them, face a battery of tests to ensure their genetic modification is successful.

Soon, millions of these engineered mosquitoes could be set loose in California in an experiment recently approved by the federal government.

Oxitec, a private company, says its genetically modified bugs could help save half the world’s population from the invasive Aedes aegypti mosquito, which can spread diseases such as yellow fever, chikungunya and dengue to humans. Female offspring produced by these modified insects will die, according to Oxitec’s plan, causing the population to collapse.

“Precise. Environmentally sustainable. Non-toxic,” the company says on its website of its product trademarked as the “Friendly” mosquito.

Scientists independent from the company and critical of the proposal say not so fast. They say unleashing the experimental creatures into nature has risks that haven’t yet been fully studied, including possible harm to other species or unexpectedly making the local mosquito population harder to control.

Even scientists who see the potential of genetic engineering are uneasy about releasing the transgenic insects into neighborhoods because of how hard such trials are to control.

“There needs to be more transparency about why these experiments are being done,” said Natalie Kofler, a bioethicist at Harvard Medical Schoolwho has followed the company’s work. “How are we weighing the risks and benefits?”

Keep reading

More evidence Covid was tinkered with in a lab? Now scientists find virus contains tiny chunk of DNA that matches sequence patented by Moderna THREE YEARS before pandemic began

Fresh suspicion that Covid may have been tinkered with in a lab emerged today after scientists found genetic material owned by Moderna in the virus’s spike protein.

They identified a tiny snippet of code that is identical to part of a gene patented by the vaccine maker three years before the pandemic.   

It was discovered in SARS-CoV-2’s unique furin cleavage site, the part that makes it so good at infecting people and separates it from other coronaviruses.

The structure has been one of the focal points of debate about the virus’s origin, with some scientists claiming it could not have been acquired naturally.  

The international team of researchers suggest the virus may have mutated to have a furin cleavage site during experiments on human cells in a lab.

They claim there is a one-in-three-trillion chance Moderna’s sequence randomly appeared through natural evolution. 

But there is some debate about whether the match is as rare as the study claims, with other experts describing it as a ‘quirky’ coincidence rather than a ‘smoking gun’. 

Keep reading

CDC finally admits, casually, that covid nasal “testing” swabs were used to sequence people’s genomes for analysis

The nation’s top “public health” agency has casually admitted that Wuhan coronavirus (Covid-19) nasal swabs are being used to sequence people’s genomes, and not necessarily to test for covid.

According to the U.S. Centers for Disease Control and Prevention (CDC), many of the cotton swab sticks that are being jammed up people’s nasal cavities and processed with a fraudulent PCR test are later collected and used by “scientists” to conduct “research” on people’s gene profiles. (Related: These same nasal swabs also punctured some people’s brain membranes, causing them to leak spinal fluid.)

“Remember that COVID-19 nose swab test you took? What happened to the swab? If it was processed with a PCR test, there’s a 10 percent chance that it ended up in a lab for genomic sequencing analysis,” the CDC announced on Twitter.

Keep reading

China Creating ‘Humanized Pigs’ with Gene Editing Then Infecting Them with Coronavirus

China’s state-run Global Times newspaper celebrated on Thursday the alleged discovery of a scientific process to create a “humanized pig” more susceptible to severe Chinese coronavirus cases, which scientists could infect and use for research.

The propaganda outlet attributed the scientific achievement to the Institute of Microbiology of the Chinese Academy of Sciences (IMCAS). The CAS, a research institution, is the world’s largest organization of its kind and a formal arm of the Chinese government. The Times published an illustrative figure on the development of “humanized” pigs that appears to have first surfaced in a study published in August that promoted the use of genetically modified pigs for Chinese coronavirus research based on how rapidly scientists could generate them and their heightened similarities with the human body.

The August study – published in Cell Discovery, a journal sponsored by the CAS, revealed that Chinese scientists had attempted to use CRISPR gene-editing technology to remove the genetic protective shields that make Chinese coronavirus not a significant threat to most pigs. CRISPR technology became the source of global controversy in 2018 after a Chinese scientist, He Jiankui, claimed to have used the method to genetically modify unborn baby twins to make them immune to HIV. The Communist Party sentenced He to three years in prison for conducting the human experiment without the full approval of the Party.

Keep reading

Government-approved Covid testing firm faces watchdog probe over plans to sell swabs with customers’ DNA for medical research

Covid-19 testing firm is under investigation after it said it planned sell DNA samples from customers to third parties for research.

The Information Commissioner’s Office (ICO), the UK’s data privacy watchdog, said it would ‘look carefully’ at information gathered about Cignpost Diagnostics over its plans to sell customers’ swabs.

The company, which was among the Covid test providers approved by the Government this year, had spoken of its plans to sell the sensitive medical data in order to ‘learn more about human health’. 

But those booking Covid tests with the firm, which trades as ExpressTest, were not clearly told their swabs could be sold to ‘collaborators’ working with the company or independently, including universities and private companies, for medical research.

They were instead asked to agree to a privacy policy which linked to another document outlining the firm’s ‘research programme’.  

It is not yet clear how many swabs Cignpost Diagnostics, which is reported to have delivered up to three million tests since it was founded in June, have kept or if any have been sold for research purposes.

Keep reading

23andMe collected people’s DNA under the guise of one purpose but will monetize it for another

Cynics will say that nothing says “trusted neighborhood doctor” quite like a company that is a cross between Big Pharma and Big Tech – but apparently Anne Wojcicki’s 23andMe wants to be perceived as having the characteristics of all three.

The company, best known for harvesting genetic data from millions of Americans via spit tests that produced questionably useful information to the customers, recently went public, and now the serious side of its business is emerging – using all that data to develop new drugs and usher in the era of a new kind of Big Pharma that relies on Big Tech strategies of collecting data and monetizing it.

It hasn’t exactly been a secret that this was the plan all along, as a report in Bloomberg now shows, citing Wojcicki’s early pitch to investors. This is not unlike what Wojcicki’s former husband, Sergey Brin, did with Google: it started out as a search engine, that once it had enough personal data harvested from users, became a massive advertising company.

Keep reading

Israel To Conduct COVID “Genetic Scanning” For All Inbound Air Passengers

The world’s most “ultra-vaxxed nation” Israel is continuing to struggle to keep its coronavirus infections down, despite enacting some of the most stringent rules and requirements on its population, including rolling out one of the earliest versions of a vaccine passport to visit public venues, which has to be “updated” each six months or so based on a booster shot timeline. 

Now Israel will go so far as to conduct “genetic scanning” for travelers arriving in the country. It’s considered a huge and experimental high tech step in screening inbound passengers for coronavirus infections at Ben Gurion International Airport in Tel Aviv.

Prime Minister Naftali Bennett made the announcement at a meeting of his cabinet on Sunday, confirming plans to eventually deploy it at Ben Gurion. “We are working on a scanning system for everyone who comes into Israel,” Bennett said. The statements were reportedly not intended to be made public, but were leaked to local Israeli media.

“Israel will thus become the radar for the virus,” he added. However, no further details on how the ‘genetic scanning’ will work were given, nor whether there might be an opt-out mechanism. Thus a Covid passport, which Israel calls its “green pass” – may be linked to an eventual regimen of forced genetic testing at international travel points.

The technology, which will no doubt be hugely controversial given privacy concerns, is being discussed as part of Israeli efforts to keep further Covid variants from entering the country, as The Times of Israel describes:

Bennett expressed support for Social Equality Minister Meirav Cohen, who had warned that “the next variant will come to Israel through Ben Gurion,” saying the proposed genetic testing would help prevent that from happening.

Conventionally since the start of the pandemic airports have often monitored passengers’ temperatures with a quick and simple thermometer scan of their foreheads, but Israeli health officials are now seeking a method which might given greater certitude over whether someone has the virus or not, and especially whether they are carrying a variant.

Keep reading